🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

62,31 USD

Máx. histórico

108,06

1030 días

Split 1:6 del 25/06/2013

Caída desde máximo

-42,34%

Rango 52 semanas

58,05 – 88,31

Variación hoy

+0,45%

Cierre anterior

62,03

Rango de hoy

62,05 – 64,37

Volumen hoy

1.699.286

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,37%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 18 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/02/2024 80,49 84,05 79,14 81,87 +0,76% 6,10% 2.391.600
01/02/2024 78,52 82,64 78,49 81,25 +3,99% 5,29% 2.678.400
31/01/2024 78,73 81,48 77,69 78,13 -0,76% 4,81% 1.954.300
30/01/2024 79,96 80,44 77,27 78,73 -1,58% 3,96% 2.154.100
29/01/2024 81,67 81,89 79,56 79,99 -3,32% 2,85% 2.472.800
26/01/2024 84,00 84,00 80,65 82,74 -0,21% 3,99% 1.163.200
25/01/2024 82,94 83,73 80,55 82,91 +1,39% 3,83% 1.737.800
24/01/2024 83,42 84,11 81,50 81,77 -3,57% 3,13% 1.723.200
23/01/2024 83,69 84,92 80,86 84,80 +1,33% 4,85% 1.404.300
22/01/2024 81,20 84,08 80,56 83,69 +3,37% 4,33% 2.058.000
19/01/2024 82,68 83,73 80,02 80,96 -2,15% 4,49% 3.382.100
18/01/2024 84,97 86,63 81,57 82,74 -3,43% 5,96% 2.547.200
17/01/2024 80,93 86,19 80,13 85,68 +5,53% 7,49% 3.378.900
16/01/2024 82,50 85,05 80,22 81,19 -5,15% 5,85% 4.057.200
12/01/2024 85,51 86,98 83,86 85,60 +0,77% 3,65% 4.878.200
11/01/2024 99,97 100,49 73,12 84,95 -16,41% 27,38% 24.190.600
10/01/2024 100,00 103,75 97,63 101,63 -0,33% 6,12% 7.236.100
09/01/2024 108,55 108,61 95,51 101,97 -5,64% 12,07% 11.769.200
08/01/2024 89,30 110,25 85,86 108,06 +15,29% 27,31% 15.904.500
05/01/2024 87,24 95,61 86,82 93,73 +6,22% 10,08% 6.530.000
04/01/2024 87,00 90,22 85,80 88,24 +1,85% 5,08% 5.876.500
03/01/2024 83,49 87,78 82,15 86,64 +3,00% 6,74% 4.546.100
02/01/2024 84,38 88,82 81,75 84,12 +0,75% 8,38% 4.437.000
29/12/2023 83,55 87,58 82,80 83,49 +0,30% 5,72% 6.323.000
28/12/2023 82,64 85,62 79,32 83,24 -0,24% 7,62% 7.191.300
27/12/2023 73,65 83,82 71,90 83,44 +82,54% 16,18% 22.099.400
26/12/2023 44,74 46,28 43,53 45,71 +2,49% 6,15% 2.001.200
22/12/2023 45,00 46,00 43,21 44,60 -0,49% 6,20% 2.673.500
21/12/2023 37,00 45,25 36,24 44,82 +25,48% 24,35% 8.780.500
20/12/2023 36,88 37,91 35,66 35,72 -3,04% 6,10% 1.765.400